WHO calls for ban on flavoured vapes, treating e-cigarettes the same as tobacco

Published On 2023-12-15 07:15 GMT   |   Update On 2023-12-15 07:15 GMT
Advertisement

London: The World Health Organization (WHO) on Thursday urged governments to treat e-cigarettes similarly to tobacco and ban all flavours, threatening cigarette companies' bets on smoking alternatives.

Some researchers, campaigners and governments see e-cigarettes, or vapes, as a key tool in reducing the death and disease caused by smoking. But the U.N. agency said "urgent measures" were needed to control them.

Advertisement

Citing studies, it said there was insufficient evidence that vapes helped smokers quit, that they were harmful to health and that they could drive nicotine addiction among non-smokers, especially children and young people.

Also Read:E-cigarettes most likely to affect young adults and adolescents with respiratory symptoms

More 13-15 year olds are using vapes than adults in all WHO regions helped by aggressive marketing, it continued.

"Kids are being recruited and trapped at an early age to use e-cigarettes and may get hooked to nicotine," said Tedros Adhanom Ghebreyesus, WHO Director-General, urging countries to implement strict measures.

Children 13–15-years old are using e-cigarettes at rates higher than adults in all WHO regions. In Canada, the rates of e-cigarette use among 16–19-year-olds has doubled between 2017–2022, and in England (the United Kingdom) the number of young users has tripled in the past three years.

“E-cigarettes target children through social media and influencers, with at least 16 000 flavours. Some of these products use cartoon characters and have sleek designs, which appeal to the younger generation. There is an alarming increase in the use of e-cigarettes among children and young people with rates exceeding adult use in many countries,” Dr Ruediger Krech, WHO Director for Health Promotion.

The WHO called for changes, including bans on all flavouring agents like menthol, and the application of tobacco control measures to vapes. Those include high taxes and bans on use in public places.

The WHO has no authority over national regulations, and only provides guidance. But its recommendations are often adopted voluntarily.

The WHO and some other anti-tobacco organisations are pushing for stricter regulations on newer nicotine products, taking aim at the alternatives on which some cigarette giants like Philip Morris International (PM.N) and British American Tobacco (BATS.L) are basing their future strategies.

Industry players like Imperial Tobacco (IMB.L) and the UK Vaping Industry Association said vapes pose significantly lower health risks than tobacco and help reduce its harms, while flavours are key in encouraging smokers to switch - a position shared by some tobacco control advocates.

Cancer Research UK, for example, says that while e-cigarettes are not risk-free and should only be used to stop smoking, there is no good evidence they cause cancer, whereas smoking causes at least 15 different kinds.

"Regulating vapes like cigarettes would only serve to reinforce misunderstandings about the relative risks of vaping and send the wrong message to smokers," said Marina Murphy, senior director of scientific and medical affairs at vaping firm ANDS, adding the WHO's position was "detached from reality".

The WHO said while long-term health risks were not understood, vapes generated some substances known to cause cancer, posed risks to heart and lung health and could affect brain development in young people.

The tobacco industry profits from destroying health and is using these newer products to get a seat at the policy-making table with governments to lobby against health policies. The tobacco industry funds and promotes false evidence to argue that these products reduce harm, while at the same time heavily promoting these products to children and non-smokers and continuing to sell billions of cigarettes, the release noted 


Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News